Clinical outcome of severe sepsis and septic shock in critically ill children

Sachin Shah1, Amita Kaul2, Yogesh Jadhav3

  • 1Director, Department of Neonatal and Pediatric Intensive Care Services, Surya Mother and Child Superspecialty Hospital, Pune, Maharashtra, India.

Tropical Doctor
|March 29, 2020
PubMed

Insights

Severe sepsis and septic shock in children with tropical infections are a significant cause of mortality in low-income countries. While many factors indicate risk, only procalcitonin levels reliably predict mortality in pediatric intensive care.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Global health

Background:

  • Limited data exists on severe sepsis and septic shock outcomes in children with tropical infections, especially in low-income settings.
  • Tropical infections pose a significant health burden, contributing to pediatric morbidity and mortality.

Purpose of the Study:

  • To investigate the clinical outcomes of severe sepsis and septic shock in children with tropical infections.
  • To identify clinical and laboratory parameters associated with mortality in this pediatric population.

Main Methods:

  • Prospective consecutive cohort study of children (1 month to 16 years) admitted to pediatric intensive care.
  • Data collected included demographics, symptoms, co-morbidities, organ dysfunction, and laboratory parameters.
  • Analysis focused on discriminating factors between survivors and non-survivors.

Main Results:

  • Respiratory and central nervous system derangements, along with cardiovascular dysfunction, were common presentations.
  • Hematological involvement was nearly universal; involvement of ≥3 organ systems increased mortality risk.
  • Dengue was the most frequent tropical infection; non-survivors were younger, had faster illness progression, and required earlier ventilation. Procalcitonin levels were the only independent predictor of mortality.

Conclusions:

  • Tropical infections causing severe sepsis and septic shock are a major cause of pediatric mortality.
  • No specific clinical parameters reliably differentiate between survivors and non-survivors.
  • Procalcitonin levels are a key indicator for mortality risk in children with severe sepsis and septic shock due to tropical infections.

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
677
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
712
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
742
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
153
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
197
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
215